MCAD Deficiency – Cavalier King Charles Spaniel
Kodas: H755
Short description
Medium-chain acyl-CoA dehydrogenase (MCAD) is an enzyme that helps the body process medium-chain fatty acids, forming a key part of an animal’s metabolism.
General information
Medium-chain acyl-CoA dehydrogenase (MCAD) is an enzyme that helps the body process medium-chain fatty acids, forming a key part of an animal’s metabolism. A recessive mutation to the gene ACADM causes an MCAD deficiency (MCADD). This results in a build-up of medium-chain fatty acids, causing neurological symptoms such as fatigue and seizures. In dogs, MCAD Deficiency is found in the Cavalier King Charles Spaniel.
Specifications
| Breeds | |
|---|---|
| Gene | ACADM |
| Chromosome | 6 |
| Mutation | c.444_445delins |
| Organ | Multiple systems |
| Specimen | Swab, Blood EDTA, Blood Heparin, Semen, Tissue |
| Mode of Inheritance | Autosomal Recessive |
| Also known as | MCAD; MCADD |
Clinical features
Dogs affected by MCADD experience a form of epileptic attacks known as complex focal seizures. These episodes are characterized by fatigue/letharghy, decreased awareness and responsiveness, and ataxia (a loss of coordination). They may last anywhere between 20 minutes to multiple hours. The onset of the disease is expected to be between 1 and 2 years of age.
References
Pubmed ID: 36292732
Year published: 2022
Omia ID: 2585
Omia variant ID:
Turnaround information
- 10 working days